APA (7th ed.) Citation

J, M., N, P., N, L., H, C., AM, G., RC, S., . . . G, P. (2022). Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis. Frontiers in immunology, 13, 1036200. https://doi.org/10.3389/fimmu.2022.1036200

Chicago Style (17th ed.) Citation

J, Marín-Prida, et al. "Anti-inflammatory Mechanisms and Pharmacological Actions of Phycocyanobilin in a Mouse Model of Experimental Autoimmune Encephalomyelitis: A Therapeutic Promise for Multiple Sclerosis." Frontiers in Immunology 13 (2022): 1036200. https://doi.org/10.3389/fimmu.2022.1036200.

MLA (9th ed.) Citation

J, Marín-Prida, et al. "Anti-inflammatory Mechanisms and Pharmacological Actions of Phycocyanobilin in a Mouse Model of Experimental Autoimmune Encephalomyelitis: A Therapeutic Promise for Multiple Sclerosis." Frontiers in Immunology, vol. 13, 2022, p. 1036200, https://doi.org/10.3389/fimmu.2022.1036200.